|
|
|
Remote ECG Screening |
| |
CompuMed, Inc.
Announces Latest Contracts to Provide Remote ECG Screening That
Reaffirm Correctional Market Dominance
Other Topics: CCHIT
Certification, NHIN National
Health Information Network Viability
BUSINESS WIRE
July 24, 2006
Winning Bid with Nebraska DOC and Renewals with Iowa and
Wyoming Secured
Los Angeles, CA -- CompuMed, Inc. (OTCBB:CMPD) -- a medical
informatics company serving the healthcare community with
diagnostic software solutions -- today announced agreements to
provide electrocardiogram (ECG) remote interpretation systems
and services for three state departments of corrections. |
| |
|
|
| |
Under the terms
of the Iowa Department of Corrections (IADOC) agreement,
CompuMed will provide remote cardiac screening on an as needed
basis for more than 8,600 detainees at all 10 of the
Department's facilities. IADOC purchased CompuMed's
state-of-the-art CardioGram System 707 as part of its effort to
fulfill the Department's mission of providing a healthy
environment and return on taxpayer' investment.
In addition, Prison Health Services (PHS) has signed a contract
extension. CompuMed will continue to serve as a value-added
partner for PHS, providing remote cardiac screening for
detainees at Wyoming correctional facilities.
Under the terms of the Nebraska Department of Correctional
Services agreement, CompuMed will provide interpretative ECG
services for the correctional system's four facilities.
"We are pleased that our correctional partners continue to renew
their agreements with CompuMed," said Jerry McLaughlin,
CompuMed's CEO. "Expanding our core ECG business is an important
part of our corporate strategy to build shareholder value. We
are also exploring ways to broaden our offering in the
telemedicine field." McLaughlin added that the three contracts
reaffirm CompuMed's dominance as the leading provider of remote
ECG screening for the correctional facility market.
CompuMed's traditional core business is providing remote ECG
interpretation terminals and related services to medical
facilities that may not have access to trained and qualified
physicians for interpreting ECG results. Customers for the
Company's CardioGram system are typically correctional
facilities, ambulatory surgery centers, occupational health
clinics and physicians' offices. The CompuMed system
significantly reduces healthcare costs by providing remote
cardiac screening at the point of care. Another key advantage is
an optional feature that automatically sends ECG results to a
trained cardiologist for an over-read when the results are
abnormal.
About PHS
Based in Brentwood, Tennessee, PHS is a leading provider of
comprehensive healthcare services for correctional systems. The
company employs more than 4,700 healthcare professionals
servicing hundreds of jails, prisons and juvenile facilities
across the United States. Visit PHS at www.prisonhealth.com.
About CompuMed
Founded in 1973, CompuMed, Inc. (OTCBB:CMPD) is a leading
provider of computer-aided telemedicine and diagnostics
technology. The Company's core products are the OsteoGram(R) and
CardioGram systems. The OsteoGram, which is cleared by the FDA
for commercial use, is an accurate and precise technology for
cost-effective osteoporosis testing. The CardioGram system
remotely interprets electrocardiograms and is used by private
practice, government and corporate healthcare providers
nationwide. CompuMed is headquartered in Los Angeles. Visit
CompuMed at www.compumed.net or call 310-258-5000.
This news release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning
CompuMed's plans, objectives, goals, strategies, future events
or performance and underlying assumptions and other statements
that are not statements of historical fact. These statements are
subject to uncertainties and risks including, but not limited
to, product and service demand and acceptance, changes in
technology, ability to raise capital, the availability of
appropriate acquisition candidates and/or business partnerships,
economic conditions, the impact of competition and pricing,
capacity and supply constraints or difficulties, government
regulation and other risks identified in the Company's filings
with the Securities and Exchange Commission. All such
forward-looking statements are expressly qualified by these
cautionary statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect
events or circumstances after the date hereof, except as
required by law.
Contacts
Tellem Worldwide
Susan Tellem, 310-479-6111, ext. 16
stellem@tellem.com |
| |
|
|
| |
|
|
